Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV–PCV2–SIV clinical infection model 2–3-months post vaccination
2008; Elsevier BV; Volume: 27; Issue: 7 Linguagem: Inglês
10.1016/j.vaccine.2008.11.105
ISSN1873-2518
AutoresTanja Opriessnig, A. R. Patterson, D. M. Madson, Narinder Pal, Patrick G. Halbur,
Tópico(s)Viral Infections and Immunology Research
Referência(s)